Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling. - Huang A; Kurhade SE; Ross P; Apley KD; Griffin JD; Berkland CJ; Farrell MP (ACS pharmacology & translational science, 2022)